BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 19125190)

  • 1. Valproate, a mood stabilizer, induces WFS1 expression and modulates its interaction with ER stress protein GRP94.
    Kakiuchi C; Ishigaki S; Oslowski CM; Fonseca SG; Kato T; Urano F
    PLoS One; 2009; 4(1):e4134. PubMed ID: 19125190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of 4-phenylbutyrate and valproate on dominant mutations of WFS1 gene in Wolfram syndrome.
    Batjargal K; Tajima T; Jimbo EF; Yamagata T
    J Endocrinol Invest; 2020 Sep; 43(9):1317-1325. PubMed ID: 32219690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic valproate treatment increases expression of endoplasmic reticulum stress proteins in the rat cerebral cortex and hippocampus.
    Chen B; Wang JF; Young LT
    Biol Psychiatry; 2000 Oct; 48(7):658-64. PubMed ID: 11032977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of endoplasmic reticulum stress proteins following chronic valproate treatment of rat C6 glioma cells.
    Bown CD; Wang JF; Young LT
    Neuropharmacology; 2000 Aug; 39(11):2162-9. PubMed ID: 10963759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mood stabilizing drug lithium increases expression of endoplasmic reticulum stress proteins in primary cultured rat cerebral cortical cells.
    Shao L; Sun X; Xu L; Young LT; Wang JF
    Life Sci; 2006 Feb; 78(12):1317-23. PubMed ID: 16236328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered gene expression in mice treated with the mood stabilizer sodium valproate.
    Chetcuti A; Adams LJ; Mitchell PB; Schofield PR
    Int J Neuropsychopharmacol; 2006 Jun; 9(3):267-76. PubMed ID: 15982445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of mood stabilizer-regulated genes by differential-display PCR.
    Wang JF; Bown CD; Chen B; Young LT
    Int J Neuropsychopharmacol; 2001 Mar; 4(1):65-74. PubMed ID: 11343631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of ER stress proteins by valproate: therapeutic implications.
    Bown CD; Wang JF; Chen B; Young LT
    Bipolar Disord; 2002 Apr; 4(2):145-51. PubMed ID: 12071512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antiapoptotic actions of mood stabilizers: molecular mechanisms and therapeutic potentials.
    Chuang DM
    Ann N Y Acad Sci; 2005 Aug; 1053():195-204. PubMed ID: 16179524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder.
    Macritchie KA; Geddes JR; Scott J; Haslam DR; Goodwin GM
    Cochrane Database Syst Rev; 2001; (3):CD003196. PubMed ID: 11687047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium-myo-inositol co-transporter (SMIT-1) mRNA is increased in neutrophils of patients with bipolar 1 disorder and down-regulated under treatment with mood stabilizers.
    Willmroth F; Drieling T; Lamla U; Marcushen M; Wark HJ; van Calker D
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):63-71. PubMed ID: 16420717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myristoylated alanine-rich C kinase substrate (MARCKS): a molecular target for the therapeutic action of mood stabilizers in the brain?
    Lenox RH; McNamara RK; Watterson JM; Watson DG
    J Clin Psychiatry; 1996; 57 Suppl 13():23-31; discussion 32-3. PubMed ID: 8970502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproate and neuroprotective effects for bipolar disorder.
    Atmaca M
    Int Rev Psychiatry; 2009; 21(4):410-3. PubMed ID: 20374154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoplasmic reticulum stress induces Wfs1 gene expression in pancreatic beta-cells via transcriptional activation.
    Ueda K; Kawano J; Takeda K; Yujiri T; Tanabe K; Anno T; Akiyama M; Nozaki J; Yoshinaga T; Koizumi A; Shinoda K; Oka Y; Tanizawa Y
    Eur J Endocrinol; 2005 Jul; 153(1):167-76. PubMed ID: 15994758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug interactions of lithium and other antimanic/mood-stabilizing medications.
    Dunner DL
    J Clin Psychiatry; 2003; 64 Suppl 5():38-43. PubMed ID: 12720483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valproate protects cells from ER stress-induced lipid accumulation and apoptosis by inhibiting glycogen synthase kinase-3.
    Kim AJ; Shi Y; Austin RC; Werstuck GH
    J Cell Sci; 2005 Jan; 118(Pt 1):89-99. PubMed ID: 15585578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutathione S-transferase is a novel target for mood stabilizing drugs in primary cultured neurons.
    Wang JF; Shao L; Sun X; Young LT
    J Neurochem; 2004 Mar; 88(6):1477-84. PubMed ID: 15009649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mood stabilizers and ion regulation.
    El-Mallakh RS; Huff MO
    Harv Rev Psychiatry; 2001; 9(1):23-32. PubMed ID: 11159930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoprotection by lithium and valproate varies between cell types and cellular stresses.
    Lai JS; Zhao C; Warsh JJ; Li PP
    Eur J Pharmacol; 2006 Jun; 539(1-2):18-26. PubMed ID: 16678157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lithium, valproate, and carbamazepine prescribing patterns for long-term treatment of bipolar I and II disorders: A prospective study.
    Musetti L; Tundo A; Benedetti A; Massimetti G; Cambiali E; Pergentini I; Del Grande C; Dell'Osso L
    Hum Psychopharmacol; 2018 Nov; 33(6):e2676. PubMed ID: 30311959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.